- Home
- WSHP vs VSTM Comparison
WSHP vs VSTM Comparison
Compare WSHP & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$6.31
Company Overview
Basic Information| Metric | WSHP | VSTM |
|---|---|---|
| Founded | 2021 | 2010 |
| Country | British Virgin Islands | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 487.8M | 470.7M |
| IPO Year | N/A | 2011 |
Fundamental Metrics
Financial Performance| Metric | WSHP | VSTM |
|---|---|---|
| Price | $15.35 | $6.31 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $14.50 |
| AVG Volume (30 Days) | 40.5K | ★ 1.4M |
| Earning Date | 01-01-0001 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.49 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $30,914,000.00 |
| Revenue This Year | N/A | $201.42 |
| Revenue Next Year | N/A | $263.25 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 209.14 |
| 52 Week Low | $13.66 | $4.01 |
| 52 Week High | $250.00 | $11.25 |
Technical Indicators
Market Signals| Indicator | WSHP | VSTM |
|---|---|---|
| Relative Strength Index (RSI) | 32.10 | 52.97 |
| Support Level | $13.66 | $5.56 |
| Resistance Level | $117.73 | $6.91 |
| Average True Range (ATR) | 5.39 | 0.33 |
| MACD | 0.82 | 0.11 |
| Stochastic Oscillator | 7.88 | 76.47 |
Price Performance
Historical Comparison WSHP
VSTM
About WSHP WeShop Holdings Limited Class A Ordinary Shares
WeShop Holdings Ltd is a community owned social commerce platform offering shoppers shares in the Company every time customers make a purchase, recommend a product or refer a new member. WeShop earns revenues from advertising on their platform and commissions on the sales through the platform.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.